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Abstract
Background: Heterotopic ossification (HO) is a frequent complication after central nervous system (CNS) damage but has
seldom been studied. We aimed to investigate features of HO for the first time in a large sample and the rate of early
recurrence of HO in terms of the time of surgery.
Methodology/Principal Findings: We retrospectively analyzed data from an anonymous prospective survey of patients
undergoing surgery between May 1993 and November 2009 in our institution for troublesome HO related to acquired
neurological disease. Demographic and HO characteristics and neurological etiologies were recorded. For 357 consecutive
patients, we collected data on 539 first surgeries for HO (129 surgeries for multiple sites). During the follow-up, recurrences
requiring another surgery appeared in 31 cases (5.8% [31/539]; 95% confidence interval [CI]: 3.8%–7.8%; 27 patients). Most
HO requiring surgery occurred after traumatic brain injury (199 patients [55.7%]), then spinal cord injury (86 [24.0%]), stroke
(42 [11.8%]) and cerebral anoxia (30 [8.6%]). The hip was the primary site of HO (328 [60.9%]), then the elbow (115 [21.3%]),
knee (77 [14.3%]) and shoulder (19 [3.5%]). For all patients, 181 of the surgeries were performed within the first year after
the CNS damage, without recurrence of HO. Recurrence was not associated with etiology (p=0.46), sex (p=1.00), age at
CNS damage (p=0.2), multisite localization (p=0.34), or delay to surgery (p=0.7).
Conclusions/Significance: In patients with CNS damage, troublesome HO and recurrence occurs most frequently after
traumatic brain injury and appears frequently in the hip and elbow. Early surgery for HO is not a factor of recurrence.
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Introduction
Heterotopic ossification (HO) is defined as the formation within
the soft tissues of abnormal, ectopic lamellar bone containing bone
marrow [1,2,3,4]. It has 3 etiologies: 1) trauma (fractures,
dislocations, post-surgery, burns), 2) genetic (fibrodysplasia ossifi-
cans progressiva (FOP), progressive osseous heteroplasia and
Albright hereditary osteodystrophy), and 3) neurologic (mainly
spinal cord injury [SCI] and traumatic brain injury [TBI]) [1,5,6].
In patients with central nervous system (CNS) damage, HO is a
frequent complication, ranging from 11% to 76% of cases
depending on the etiology and the study because of varied
diagnostic criteria [7,8,9]. Symptomatic HO develops in approx-
imately 10% of patients with TBI [10,11,12]. In SCI, the HO
frequency varies from 5% to 60% depending on the study and
whether the diagnosis is based on clinical symptoms or standard
radiography results [13,14,15,16].
The etiopathogenesis of HO is poorly understood [2]. CNS
damage is believed to activate local factors such as bone
morphogenic protein or systemic factors such as prostaglandin
E2, or both [1,4,6]. These factors could induce bone-forming
mesenchymal cells to differentiate to osteoblasts in the periphery of
the muscle and stimulate the formation of bone[1,4,12,17].
Another potential mechanism is the disruption of joint proprio-
ception after neurologic damage, thus changing the relationship
among the different peri-articular tissues [18]. For patients with
TBI, osteogenic blood factors have been suggested[12,17].
For patients with CNS damage, HO causes pain, inflammation
and loss of range of motion (ROM) as the joint gradually becomes
ankylosed [4,5,12,19,20]. The condition may have major
repercussions on function, with, in many cases, loss of indepen-
dence [2,6]. Currently, the only effective treatment is surgery
[4,5,19,20,21]. Indications for surgery have changed recently [4].
Until recently, surgery was delayed until the HO was fully formed
[4,21,22,23,24], and studies of small samples of patients (analyzed
by reviews) have suggested that the rate of recurrence is not
affected by HO maturity [4,25,26]. Indications for surgery relate
to vascular or neurological involvement, effect on function,
hygiene (e.g., access to the perineum) and pain [5,20,26]. Surgery
can be performed as soon as co-morbidity factors are under
control, even in patients with major neurologic damage due to the
original abnormality (e.g., TBI) [2,26,27,28].
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features of HO (incidence, recurrence, localization) in adult
patients with CNS lesions [25]. Furthermore, these studies
included few patients [2,10,13,26,29]. The most important series
was published by Garland et al., in 1980; the incidence of HO was
11% in a cohort of 496 patients with TBI in a physical medicine
and rehabilitation unit [10]. In 2005, Fuller et al. reported on 17
patients with 22 knee HO in a retrospective analysis [19],
Simonsen et al. in 2007, reported on 13 patients with HO in 21
locations in a prospective cohort of 114 patients with TBI [29],
and Melamed et al. reported on 12 excisions for HO in 9 patients
with TBI [26].
We aimed to investigate a neuro-orthopedic complication —
HO requiring surgery – in a large cohort of patients with CNS
damage admitted to an orthopedic and trauma hospital ward. This
unit is part of a tertiary-care teaching hospital specialized in
medical treatment, surgery and rehabilitation for motor handicap.
We also investigated the rate of recurrence of HO in terms of time
to surgery. Results from this large survey might help establish
recommendations for treating HO after CNS damage.
Methods
Objectives
The objectives are to investigate features of HO for the first time
in a large sample of patients and notably to assess if the time of
surgery is associated with the risk of early recurrence of HO.
Participants
This prospective data survey involved consecutive patients
undergoing surgery between May 1993 and November 2009 for
HO of a joint after CNS injury. Patients with previous removal of
HO (before their inclusion in the study) who presented recurrence
or could not be followed up by the surgeon or the physical
medicine and rehabilitation physician for a minimum of 6 months
were excluded, as were those without an initial neurologic
aetiology.
Description of Procedures or Investigations undertaken
Patients were referred for a specialized neuro-orthopedic
consultation for troublesome HO. Indications for surgery were
loss of ROM with functional repercussion, ankylosed joint, and
nerve or vessel compression. The surgery and immediate post-
operative assessment were performed by the same surgeon.
The following data were collected during consultation by
questionnaire and medical records : sex; etiology of the CNS
damage (ischemia or hemorrhage for stroke; tetraplegia or
paraplegia for SCI, with lesion level; brain-associated lesion
[TBI or cerebral anoxia (CA)] and American Spinal Injury
Association [ASIA] score [30]); age at CNS damage and at
surgery; delay from neurologic trauma to surgery; affected joints;
type of HO for the surgical approach of Garland (for incision) [7]
(from radiography and computed tomography [CT] scanning:
anterior, posterior, internal [anterior and posterior], external
[anterior and posterior], and encircling); area of residence (Paris
area [Ile de France], near Ile de France, between 200 and 400 km
from Ile de France, more than 400 km from Ile de France, and
foreign countries and French overseas departments and territo-
ries); and follow-up (last consultation, months). Finally, data were
collected on complications, especially sepsis and HO recurrence.
Several patients had received prophylactic treatment for HO, such
as a nonsteroidal anti-inflammatory drug (for pain) into their
upstream structure. Radiation therapy was rarely used by the
upstream units.
A standardised surgical approach was used for each location of
the HO. The surgical goal was resection of the necessary amount
of bone to allow for restoration of motion in all planes.
Postoperatively, gentle mobilization was started on the second
day, and progressed as tolerated. A non-steroidal anti-inflamma-
tory agent, ketoprofene, was given for 10 days after surgery.
Neither radiation therapy (RT) nor indomethacin was used after
surgery. RT was never carried out after surgery mainly because
the post-operative management of such a treatment is too
complicated for these kinds of patients. RT was sometimes
administered before surgery but only when recurrence occurred
(14/31 cases). The main reason was that we are not aware of any
evidence demonstrating the efficacy of RT for HO after central
nervous system damage. The recurrence rate was very low and
well distributed across the 16 years of this study. As there are no
recommendations for patients with neurological lesions, we used
the same RT protocol as for hip arthroplasty in the patients who
received pre-operative RT (4 hours before surgery, 7 to 10 Gy)
[31].
Patients were followed up in the rehabilitation unit of the same
institution for surgery if they lived locally or by medical
consultation if they lived far away. Each patient underwent
regular clinical and radiography examinations; they were
hospitalized in a surgical care unit for about 1 week, then received
regular consultations in rehabilitation units (inpatient care
followed by outpatient care for a minimum of 1 year). All patients
received intravenous peri-operative antibiotic prophylaxis and
anticoagulation medication.
Ethics
The study was approved by the local institutional review board.
It was a non-interventional study with usual procedures and
without additional procedures (diagnosis or medical supervision).
In France, patient consent is not needed for such an anonymous
retrospective data analysis. We confirm that the named institu-
tional review board specifically waived the need for consent for this
study [Comite ´ de Protection des Personnes Ile de France XI
Pavillon Jacques Courtois - 2e `me e ´tage 20, rue Armagis 78105
Saint Germain en Laye Cedex. te ´l : 01.39.27.42.58 - fax :
01.39.27.49.01 mail : cppidf11@chi-poissy-st-germain.fr"]
Statistical methods
Statistical analysis involved use of SASH v9.1 (SAS Inst., Cary,
NC). Data are reported as median, interquartile ranges (IQRs) and
numbers and percentages. The chi-square test was used to
compare normally distributed qualitative variables and the Fisher
test for no normally distributed data. ANOVA was used for
analysis of continuous variables, and if significant, the Student t
test was used to compare groups with the nearest values. All p
values were two tailed, and a p,0.05 was considered statistically
significant.
Results
Demographic data (Table 1)
Of 402 consecutive patients undergoing surgery for HO
between May 1993 and November 2009, 363 with neurologic
damage met our inclusion criteria (Fig. 1). Data for the few
patients with cerebral palsy (4 patients), multiple sclerosis (1
patient) and Guillain-Barre ´ syndrome (1 patient) were excluded
from the analysis. Thus, we analyzed the data for 357 patients (70
females) who underwent 570 surgeries: 539 (94.2%) were first
surgeries (multiple sites for 129 patients: 2 surgeries for 97 patients,
3 for 18; 4 for 9, 5 for 3 and 6 for 2) and 31 were for recurrences
Heterotopic Ossification after Neurological Damage
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3.8–7.8%).
The median delay from neurological trauma to the first surgery
was15.7months(IQR9.2to37.5months)(Table1),andthemedian
delaywith multi-siteHOwas 16.7months(IQR9.9 to 40.0 months).
Most cases of HO were related to TBI (199 patients [55.7%], 304
surgeries[56.4%]),thenSCI (86 patients[24.1%];56 paraplegiaand
30 tetraplegia; 129 surgeries [23.9%]), stroke (42 patients [11.8%],
10 ischemia and 32 hemorrhage; 55 surgeries [10.2%]) and CA (30
patients [8.6%]; 51 surgeries [9.5%]). The median follow-up by the
surgeon was 6.9 months (IQR 5.7 to 19.4 months).
The presence of multiple sites of HO occurred more frequently
in patients with CA (16/30; 14 patients with 2 locations, 1 patient
with 3 locations and 1 patient with 6 locations) and TBI (74/199;
53 patients with 2 locations, 14 with 3 locations, 4 with 4 locations
and 3 with 5 locations) than with SCI (29/86; 14/56 with
paraplegia, 15/30 with tetraplegia; 22 with 2 locations, 2 with 3
locations, 4 with 4 locations and 1 patient with 6 locations) and
Table 1. Demographic Data for Patients Undergoing Surgery for Heterotopic Ossification After Central Nervous System (CNS)
Damage.
Patient parameters
TBI
n=199
(55.7)
Stroke
n=42
(11.8)
SCI
n=86
(24.1)
CA
n=30
(8.4)
Total
n=357
(100)
Male (%) 159
(79.9)
26
(61.9)
81
(94.2)
21
(70.0)
287
(80.4)
Age at time of CNS
damage (yr)
median
interquartile range
30.6
23.6–38.8
45.7
37.9–51.5
27.1
21.3–34.7
44.9
32.2–48.3
32.4
24.6–43.3
Age at time of surgery (yr)
Median
interquartile range
32.2
26.2–41.2
49.7
40.5–54.3
34.7
27.1–42.7
46.5
34.3–49.3
35.4
27.6–46.7
Delay from CNS damage
to first surgery (months)
Median
interquartile range
13.1
8.3–29.0
15.2
9.5–34.7
24.1
13.4–72.4
12.7
9.5–21.0
15.7
9.2–37.5
HO: Heterotopic Ossification; TBI: traumatic Brain Injury; SCI: Spinal Cord Injury; CA: Cerebral Anoxia; CNS: Central Nervous System.
doi:10.1371/journal.pone.0016632.t001
Figure 1. Flow chart of the patients’ selected files.
doi:10.1371/journal.pone.0016632.g001
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locations and 1 patient with 4 locations).
HO surgery side effects
The main side effects were sepsis (16; 3.0%) and HO recurrence
(31; 5.8%). All patients with sepsis underwent secondary surgery.
Sepsis occurred mainly after SCI (12), then TBI (3) and stroke (1).
All patients with HO recurrence underwent secondary surgery.
Recurrences occurred after TBI (16), stroke (2), SCI (10), and CA
(3). In total, 27 patients (15 with multisite HO) had 1 recurrence
and 4 patients (all with multisite HO) had 2 recurrences on 2
different joints. HO recurrence concerned only the hip (25
recurrences) and the elbow (6). Recurrence was more frequent for
patients with multisite HO (15/27; 55.6%) than for all patients
(127/357; 35.6%). For the 15 patients with multisite HO,
recurrence never appeared after the first surgery but after a later
surgery on a different site. For 181 surgeries performed within the
first year after the CNS damage, no recurrence was reported at 6-
month follow-up.
HO sites (Table 2)
For all first surgeries (all etiologies combined), the primary site
for HO was the hip joint (328/539; 60.9%). Hip HO occurred
most frequently with SCI (96/129; 74.4%) and stroke (40/55;
72.7%). Elbow HO was the next most affected joint (115/539,
21.3%), then the knee (77/539; 14.3%) and shoulder (19/539;
3.5%). Elbow HO occurred most frequently in patients with TBI
(85/304; 28.0%) and CA (12/51; 23.5%). Knee HO occurred
most frequently in patients with SCI (19/129; 14.7%; 7 for
paraplegia, 2 bilateral; and 6 for tetraplegia, 4 bilateral), stroke (8/
55; 14.1%) and TBI (43/304; 14.1%). The ratio of knee to hip HO
(81.0%) and shoulder to elbow HO (85.8%) was similar for all
etiologies.
Lower-limb HO sites (Table 3)
HO in the anterior and internal hip represented 60.0% of the
total sites. This incidence was highest for patients with stroke
(74.4%), then SCI (70.7%), TBI (51.9%) and CA (50.0%). The
principle site of knee HO was internal (77.3%). This incidence was
highest for patients with stroke (87.5%), then SCI (84.1%), TBI
(75.5%) and CA (57.1%).
Upper-limb HO sites (Table 3)
The main site of elbow HO was posterior and internal (82.7%).
Similar to hip HO, this incidence was highest for patients with SCI
(100.0%; all tetraplegia and 1 paraplegia with associated elbow
fracture) and stroke (100.0%), then TBI (81.2%) and CA (66.7%).
Only 5 patients with paraplegia exhibited HO in the upper limbs:
4 had an associated brain injury (2 with HO in shoulders and 2
elbows) and one a medical SCI with HO after elbow fracture.
Only 19 occurrences of HO (3.5%) were in the shoulder joint, and
the main sites were internal (41.2%), posterior (23.5%) and
encircling (23.5%).
Univariate analysis of data for patients (Tables 4)
When analyzing data for patients (n=357), we found a
significant association between etiology and delay until first
surgery (F=11.5; p,0.01). The shortest delay was observed for
CA (12.7 months; IQR 9.5 to 21.0 months), then stroke, TBI and
SCI. We found a significant difference between delay until first
surgery for SCI (the longest delay) and for stroke (the nearest from
SCI) (F=7.38; p,0.01). We suggest that differences between SCI
and the other 2 etiologies (TBI and CA) are significant also. We
did not find an association of etiology and multiple-site HO
(p=0.1). Recurrence was not associated with etiology (p=0.46),
sex (p=1.00), or multisite HO (p=0.34).
Univariate analysis of time from CNS damage related to
HO recurrence (Table 5)
When analyzing data for patients (n=357), recurrence was not
associated with age at CNS damage (F=1.65; p=0.20) or delay
from CNS damage to first surgery (months) (F=0.13; p=0.7). For
all surgeries, (including multisite HO), recurrence was not
associated with delay from CNS damage to surgery (months)
(F=2.35; p=0.13).
Discussion
HO is a frequent complication after CNS damage. This survey
of a large sample of patients with CNS damage revealed that most
HO requiring surgery occurred after TBI, then SCI, stroke and
CA. Multi-site HO was most frequently due to CA and TBI. For
all patients, the hip was the primary site of damage, then the
elbow, knee and shoulder. The median time from CNS damage to
surgery for all etiologies was 15.7 months (IQR 9.2 to 37.5
months), which was shorter than that for SCI (24.1 months; IQR
13.4 to 72.4 months). For all patients, 181 of the surgeries were
performed within the first year after the CNS damage, without
recurrence at 6-month follow-up. Recurrence was not associated
with etiology, sex, age at CNS damage, multisite HO, or delay
from CNS damage to surgery, whether analyzing data for patients
or surgeries. No association was found between etiology and
multisite HO or articulation location of HO. These results suggest
that surgery could be proposed as soon as HO becomes
troublesome.
In our survey, HO was mainly observed in 4 etiologies and very
rarely in other disorders such as multiple sclerosis (1), cerebral
palsy (4), or Guillain-Barre ´ syndrome (1). Our observations are
unlikely due to recruitment bias because our institution, in charge
of the National Adult CP Network, is the main site for HO
management in France. This is suggested by our geographical
recruitment [Ile de France 220 (63.9%); near Ile de France 41
(11.9%); between 200 and 400 km from Ile de France 22 (6.4%);
more than 400 km from Ile de France 23 (6.7%); and foreign
countries or French overseas departments and territories 38
(11.1%)]. Better risk factors for HO have been reported to be
Table 2. Sites of Heterotopic Ossification (HO) in Patients
Undergoing Surgery After Central Nervous System Damage.
Location of
HO
TBI
n=304
Stroke
n=55
SCI
n=129
CA
n=51
Total
n=539
Hip – no.
(%)
163 (53.6) 40 (72.7) 96 (74.4) 29 (56.9) 328 (60.9)
Knee – no.
(%)
43 (14.1) 8 (14.6) 19 (14.7) 7 (13.7) 77 (14.3)
Shoulder –
no. (%)
13 (4.3) 1 (1.8) 2 (1.6) 3 (5.9) 19 (3.5)
Elbow – no.
(%)
85 (28.0) 6 (10.9) 12 (9.3) 12 (23.5) 115 (21.3)
Total – no.
(%)
304 (56.4) 55 (10.2) 129 (23.9) 51 (9.5) 539 (100)
Data are for Number of First Surgeries Performed.
TBI: traumatic brain injury; SCI: spinal cord injury; CA: cerebral anoxia; CNS:
central nervous system.
doi:10.1371/journal.pone.0016632.t002
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lesions, spasticity, systemic infection, and overall dysautonomia,
which is a high predictive factor of HO [11,25]. These risk factors
may explain why HO was observed mainly for patients with CA,
TBI, SCI and stroke. Furthermore, notably after TBI, neurolog-
ical repercussions affect the whole organism and probably also
bone hormonal control [32].
As suggested by Garland et al., we found that the main site of
HO was the hip (60.9%), then the elbow (21.3%), knee (14.3%)
and shoulder (3.5%) [10]. The high incidence in the hip may be
linked to HO in this joint having large repercussions on function
(e.g., ability to sit, lie or stand). The high incidence in the elbow
may be linked to the frequency of ulnar nerve compression, which
is a strong indication for surgery. Furthermore, HO often occurred
below the level of the CNS lesion in patients with SCI, which may
explain the high incidence of lower-limb HO in this group. For the
hip, the sites of HO seem to depend on the abnormality: the most
frequent site for SCI was anterior (51.1%) but antero-medial for
stroke (43.6%). This finding could reflect joint-related constraints,
which differ according to muscle control. However, this hypothesis
needs to be confirmed with further studies. For all etiologies, the
most frequently affected site was medial for the knee (54.7%) and
medial, antero- and postero-medial for the elbow (57.3%). These
results could be explained by these particular locations having the
worse repercussions (e.g., functional, compressive) and therefore
needing surgery.
Currently, the only effective treatment for HO is surgery
[4,5,6,21]. Indications for surgery have changed recently [4]. In
our experience, surgery is indicated when HO causes loss of
function, when pain is difficult to manage medically or with risk of
nerve or, more rarely, vessel involvement. In our study, the
median time from CNS damage to surgery was 15.7 months
(range 9.2 to 37.5 months). This delay was significantly shorter
than that for patients with SCI (24.1 months, range 13.4–72.4
months). Discomfort is likely to be a problem earlier in conditions
other than SCI because of the typical loss of sensation in SCI and
the different functional prognosis.
Some studies, with a small sample of patients with HO, have
suggested that early surgery does not increase the rate of
recurrence [4,21,25]. In our survey, recurrence was not associated
with delay from CNS damage to surgery, whether considering
patients or surgeries. None of the 181 patients who underwent
surgery within a year of the CNS damage experienced HO
recurrence during follow-up. In addition, 4 patients with
recurrence had previously benefitted from surgery for troublesome
HO on another location without recurrence. The minimum
follow-up by the surgeon in our study was 3 months. In our
experience, recurrences requiring surgery appear sooner than 3
Table 3. Sites of Heterotopic Ossification of Patients Undergoing Surgery for Central Nervous System Damage. Data are for
Number of First Surgeries Performed.
Site Hip Knee
TBI
n=304
Stroke
n=55
SCI
n=129
CA
n=51
Total
n=539
TBI
n=304
Stroke
n=55
SCI
n=129
CA
n=51
Total
n=539
Anterior – no. (%) 27 (16.9) 9 (23.1) 46 (50.0) 6 (23.1) 88 (27.8) 2 (4.9) 0 (0.0) 1 (5.3) 0 (0.0) 3 (4.0)
Posterior – no. (%) 29 (18.1) 1 (2.6) 12 (13.0) 7 (26.9) 49 (15.5) 4 (9.8) 0 (0.0) 0 (0.0) 0 (0,0) 4 (5.3)
Internal – no. (%) 56 (35.0) 20 (51.3) 19 (20.7) 7 (26.9) 102 (32.2) 31 (75.5) 7 (87.5) 16 (84.1) 4 (57.1) 58 (77.3)
External – no. (%) 28 (17.5) 7 (17.9) 3 (3.3) 2 (7.7) 40 (12.6) 2 (4.9) 1 (12.5) 1 (5.3) 1 (14.3) 5 (6.7)
Encircling – no. (%) 20 (12.5) 2 (5.1) 12 (13.0) 4 (15.4) 38 (11.9) 2 (4.9) 0 (0.0) 1 (5.3) 2 (28.6) 5 (6.7)
Total 160 (50.5) 39 (12.3) 92 (29.0) 26 (8.2) 317 (100) 41 (54.7) 8 (10.7) 19 (25.3) 7 (9.3) 75(100)
Site Shoulder Elbow
TBI
n=304
Stroke
n=55
SCI
n=129
CA
n=51
Total
n=539
TBI
n=304
Stroke
n=55
SCI
n=129
CA
n=51
Total
n=539
Anterior – no. (%) 0 (0.0) 0 (0.0) 2 (100.0) 0 (0.0) 2 (11.8) 3 (3.8) 0 (0.0) 0 (0.0) 2 (16.7) 5 (4.6)
Posterior – no. (%) 4 (40.0) 0 (0.0) 0 (0.0) 0 (0.0) 4 (23.5) 22 (27.5) 0 (0.0) 3 (25.0) 3 (25.0) 28 (25.4)
Internal – no. (%) 4 (40.0) 1 (100.0) 0 (0.0) 1 (33.3) 6 (41.2) 43 (53.7) 6 (100.0) 9 (75.0) 5 (41.7) 63 (57.3)
External – no. (%) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 12 (15.0) 0 (0.0) 0 (0.0) 0 (0.0) 12 (10.9)
Encircling – no. (%) 2 (20.0) 0 (0.0) 0 (0.0) 2 (66.7) 4 (23.5) 0 (0.0) 0 (0.0) 0 (0.0) 2 (16.7) 2 (1.8)
Total 10 (62.5) 1 (6.3) 2 (12.5) 3 (18.7) 17 (100.0) 80 (72.7) 6 (5.5) 12 (10.9) 12 (10.9) 110 (100.0)
doi:10.1371/journal.pone.0016632.t003
Table 4. Univariate Analysis of Data for Patients (n=357).
Variables p (F statistic) p
Etiology
Delay until first
surgery
,0.01* (11.46)
Delay until first
surgery for SCI
and stroke
,0.01* (7.38)
Multisite HO 0.1
Recurrence
Multisite HO 0.34
Sex 1.00
Etiology 0.46
SCI = spinal cord injury; HO = heterotopic ossification
HO: heterotopic ossification; TBI: traumatic brain injury; SCI: spinal cord injury;
CA: cerebral anoxia; CNS: central nervous system.
doi:10.1371/journal.pone.0016632.t004
Heterotopic Ossification after Neurological Damage
PLoS ONE | www.plosone.org 5 January 2011 | Volume 6 | Issue 1 | e16632months. Furthermore, most patients who underwent surgery for
HO came from units in close contact with our institution, and, in
cases of recurrence, the surgeon is contacted quickly. Likewise,
after 6 months, patients were followed up by a physical and
medical rehabilitation physician. Therefore, recurrences were
unlikely to be undiagnosed and unreported.
Several other groups have assessed the effect of delayed surgery
on HO. Lazarus et al. studied 24 patients who underwent surgery
for elbow HO and found that a long delay before surgery was a
negative predictor of recovery of ROM [33]. This finding is
reinforced by the new approaches in neuro-rehabilitation
involving limited ROM. Limited ROM may induce plastic
cerebral changes, such as atrophy of motor areas with time, and
therefore reduce recovery capacity after ROM has been restored
[34]. However, several studies suggested that the more limited
the ROM in the pre-operative joint, the better the surgical
outcome[33,35]. The sooner the troublesome HO is treated by
surgery, the better the functional outcome. Moreover, in a
previous study we found that a long delay before surgery can be
deleterious, especially for the ankylosis state: often considerable
bone loss of articular structure (i.e., femoral head) and high risk of
peri-operative fracture [20]. Because of our large sample size, our
results demonstrate that delay is not a criterion to decide surgery,
as was suggested by our previous work [20], systematic reviews
and other previous studies with limited sample size [4,6,25,26].
Almost half of the patients experiencing recurrence (15 of 31) had
multisite HO, so this after-effect might occur more in patients with
a global increase of bone activity. However, recurrence was not
associated with etiology, sex or age at CNS damage.
According to Garland et al. [36], after SCI, there is a significant
relationship between hip HO volume and recurrence risk. Garland
proposed a ‘‘subjective’’ radiological grading system in a spinal
cord injured group of patients (19 patients with 24 HO). There
were 5 grades (from minimal to ankylosis), only for the hip.
Previously, Brooker et al. (1973) proposed a radiological scale for
post operative patients (after total hip arthroplasty) [37]. There
were 4 classes (from ‘‘Island of bone within the soft tissues about
the hip’’ to ‘‘apparent bone ankylosis of the hip’’) and again only
for the hip. Stover et al. (1991) proposed to extend this
classification for other articulations and aetiologies and mainly
after neurological diseases [16]. Finally, Stover suggested (without
carrying out a statistic analysis) that the higher the Brooker status,
the higher the recurrence risk [16,37]. Unlike the results of these
studies, in our series, the pre-operative extent of HO does not
seem to influence the recurrence risk. However, our database is
quite varied, containing many aetiologies (4), articulations (4) and
surgical indications (functional disabilities, pain, nerve and vessel
compressions, hygienic access…) making it difficult to draw
reliable conclusions regarding the implication of the volume of
preoperative HO in the recurrence risk. Further studies should be
carried out on sub-populations of this database (i.e. after TBI and
Hip HO). Furthermore, we specify that, in our series, all patients
undergoing symptomatic HO were classified as Brooker level 3 or
4 for the hip. As we stated above, we believe the most pertinent
risk factors are clinical such as aetiology (SCI), an infectious
context (bacteriuria, slough, post operative or post traumatic sepsis
such as open fracture), spasticity and the severity of the
neurological initial damage.
Our results can be generalized only to patients with HO
requiring surgical intervention, not those with HO in general. The
prevalence of HO risk is probably underestimated slightly because
non-symptomatic cases remain undiagnosed. As well, our study
was monocentric, which may influence the generalizability of
results. However, our center is a national reference center of
rehabilitation, and our large sample size and our patients admitted
from a large geographical area should limit questions of
recruitment bias.
In conclusion, we performed a large-sample study of HO, a
frequent complication after CNS damage but rarely studied, to
illuminate features of HO associated with etiology and other
factors. In patients with CNS damage, troublesome HO and
recurrence occurred most frequently in those with TBI and
appeared frequently in the hip and elbow. Early surgery for HO is
not a factor of recurrence. Therefore, troublesome HO is the main
factor indicating surgery.
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